KBC Securities advice for Teva Pharmaceuticals
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| August 04, 2018 | KBC Securities | Teva Pharmaceuticals | Sell | 16.00 USD | 44.19 % |
Advice details
Brussels - Op 04 aug herhalen de analisten van KBC Securities hun verkoopadvies voor de Amerikaanse pharmaceut Teva Pharmaceuticals (ISIN: US8816242098 / Mnemo: TEVA). Het 12-maands koersdoel wordt opwaarts bijgesteld van 14.0 USD naar 16.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 